Literature DB >> 33718990

Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

Keyvan Kiakojuri1, Saeid Mahdavi Omran2, Somayeh Roodgari3,4,5, Mojtaba Taghizadeh Armaki6, Mohammad Taghi Hedayati3,4, Tahereh Shokohi3,4, Iman Haghani3,4, Javad Javidnia3,4,5, Firoozeh Kermani3,4,5, Hamid Badali3,4, Mahdi Abastabar7,8.   

Abstract

Fungal otitis externa, an infection of the external auditory canal caused by molds and yeasts, accounts for approximately 10-20% of ear canal infections accompanying high recurrence. The purpose of the current study was to assess the pattern of etiological agents of otomycosis and resistance profile as well as the rate of tympanic membrane perforation. A total of 1040 patients with symptoms of fungal otitis externa, in a period of two years, were investigated. The mycological tests revealed the presence of different fungi in 237 ears (22.8%). Fungal otitis was more related to filamentous fungi of the species Aspergillus flavus (54.43%), A. tubingensis (10.97%), and A. niger (8.86%), followed by yeasts, Candida orthopsilosis (7.59%), C. albicans (6.75%), and C. parapsilosis (5.06%). Tympanic membrane perforation rate was found to be 6.75% and was more common with otomycosis caused by A. flavus, A. tubingensis and C. albicans. In antifungal susceptibility tests, all tested drugs showed generally good activity against most isolates of molds and yeasts, while tolnaftate, clotrimazole, nystatin, and terbinafine had lowest effects. We found that among Aspergillus isolates, one A. niger isolate was resistant to voriconazole, and one A. flavus isolate was resistant to amphotericin B. Furthermore, among Candida species, three isolates of C. orthopsilosis showed high MIC values to fluconazole, two C. albicans isolates were considered fluconazole resistant and one isolate of C. parapsilosis was resistant to caspofungin and 3 isolates were resistant to fluconazole. Regarding the existence of the cases with perforated tympanic membrane and emerging species causing fungal otitis in the current report, the importance of the early physical examination, precise molecular identification, and the antifungal susceptibility evaluation is highlighted.

Entities:  

Keywords:  Aspergillus flavus; Candida albicans; Otomycosis; Resistance; Tympanic membrane perforation

Year:  2021        PMID: 33718990     DOI: 10.1007/s11046-021-00537-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  58 in total

1.  Otomycosis: prevalence, clinical symptoms, therapeutic procedure.

Authors:  P Kurnatowski; A Filipiak
Journal:  Mycoses       Date:  2001-12       Impact factor: 4.377

Review 2.  Otomycosis: Diagnosis and treatment.

Authors:  Irina Vennewald; Eckart Klemm
Journal:  Clin Dermatol       Date:  2010-03-04       Impact factor: 3.541

Review 3.  Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review.

Authors:  Borlingegowda Viswanatha; Dadarao Sumatha; Maliyappanahalli Siddappa Vijayashree
Journal:  Ear Nose Throat J       Date:  2012-03       Impact factor: 1.697

4.  Otomycosis in Shanghai: aetiology, clinical features and therapy.

Authors:  Xianhao Jia; Qin Liang; Fanglu Chi; Wenjun Cao
Journal:  Mycoses       Date:  2011-10-17       Impact factor: 4.377

5.  Otomycosis: clinical features and treatment implications.

Authors:  Tang Ho; Jeffrey T Vrabec; Donald Yoo; Newton J Coker
Journal:  Otolaryngol Head Neck Surg       Date:  2006-11       Impact factor: 3.497

6.  Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis.

Authors:  A del Palacio; M S Cuétara; M J López-Suso; E Amor; M Garau
Journal:  Mycoses       Date:  2002-10       Impact factor: 4.377

7.  The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.

Authors:  Shigehiro Hagiwara; Takashi Tamura; Kazuo Satoh; Hitoshi Kamewada; Masayasu Nakano; Seiichi Shinden; Hideyo Yamaguchi; Koichi Makimura
Journal:  Mycopathologia       Date:  2018-10-05       Impact factor: 2.574

8.  Otomycosis With Tympanic Membrane Perforation: A Review of the Literature.

Authors:  Petros Koltsidopoulos; Charalampos Skoulakis
Journal:  Ear Nose Throat J       Date:  2019-05-29       Impact factor: 1.697

9.  Bayesian analysis of two methods MALDI-TOF-MS system and culture test in otomycosis infection.

Authors:  Sibanarayan Rath; Saumya Ranjan Das; Rabindra Nath Padhy
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2019-01-04

10.  Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.

Authors:  Khaled Ali; Mahmood A Hamed; Hameda Hassan; Amira Esmail; Abeer Sheneef
Journal:  Int Arch Otorhinolaryngol       Date:  2018-04-12
View more
  2 in total

Review 1.  Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.

Authors:  Javad Javidnia; Zahra Ghotbi; Aynaz Ghojoghi; Kavous Solhjoo; Mohamed Mahdi Alshahni; Seyed Ali Jeddi; Bahram Ahmadi; Sadegh Nouripour-Sisakht; Saham Ansari; Gholamreza Shokoohi
Journal:  Mycopathologia       Date:  2022-03-26       Impact factor: 2.574

2.  Identification of the Fungal Community in Otomycosis by Internal Transcribed Spacer Sequencing.

Authors:  Xiaona Gu; Xiangrong Cheng; Jinhua Zhang; Wandong She
Journal:  Front Microbiol       Date:  2022-03-15       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.